fluorouracil has been researched along with Pseudomyxoma Peritonei in 49 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Pseudomyxoma Peritonei: A peritoneal adenocarcinoma characterized by build-up of MUCUS in the PERITONEAL CAVITY. Mucus secreting cells may attach to the peritoneal lining and continue to secrete mucus. The majority of cases represent tumor spread from a primary low-grade mucinous neoplasm of the APPENDIX (NCI Thesaurus).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pseudomyxoma peritonei, a tumor which spreads chiefly along peritoneal surfaces, has recently been treated by resection followed by intraperitoneal infusion of 5-fluorouracil (5-FU)." | 7.70 | Pseudomyxoma peritonei: Sudden cardiac death complicating post operative intraperitoneal treatment with 5-fluorouracil. ( El-Attar, AF; Howard, JM; Skeel, RT, 1999) |
| "Four patients with pseudomyxoma peritonei associated with mucinous tumors of the ovary were treated with cytoreductive surgery followed by intraperitoneal (IP) 5-fluorouracil (5-FU)." | 7.68 | Pseudomyxoma peritonei: treatment with intraperitoneal 5-fluorouracil. ( Given, FT; Kemp, GM; Nasr, MF, 1993) |
| "Intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil has been used to rescue patients from peritoneal carcinomatosis after perforated cystadenocarcinoma of the large bowel or appendix." | 7.68 | Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. ( Jaffe, G; Landy, D; Pascal, R; Sugarbaker, PH, 1990) |
| "The purpose of our study was to determine the maximum-tolerated dose, dose-limiting toxicity, safety profile, and pharmacokinetics of the polyamine synthesis inhibitor SAM486A given in combination with 5-fluorouracil/leucovorin (5-FU/LV) in cancer patients." | 6.71 | Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer. ( Bootle, D; Bridgewater, J; Choi, L; de Bruijn, P; Eskens, FA; Ledermann, JA; Mueller, C; Planting, AS; Sklenar, I; Sparreboom, A; van Zuylen, L; Verweij, J, 2004) |
| "We retrospectively evaluated the efficacy and safety of a chemotherapeutic regimen with 5-fluorouracil and oxaliplatin (modified FOLFOX6, mFOLFOX6) for patients with unresectable pseudomyxoma peritonei." | 3.96 | Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei. ( Hiraide, S; Imai, H; Ishioka, C; Komine, K; Ouchi, K; Saijo, K; Sato, Y; Shirota, H; Takahashi, M; Takahashi, S, 2020) |
| "Ten patients with histologically diagnosed peritoneal metastases of adenocarcinoma or pseudomyxoma peritonei underwent cytoreductive surgery and received HIPEC with 5-fluorouracil for 90 min, delivered via our modified system." | 3.83 | Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin. ( Cavazos, M; Cravioto-Villanueva, A; Esquivel, J; Luna-Perez, P; Martinez-Gomez, H; Montiel, H; Ramirez, ML; Solorzano, J, 2016) |
| "Pseudomyxoma peritonei, a tumor which spreads chiefly along peritoneal surfaces, has recently been treated by resection followed by intraperitoneal infusion of 5-fluorouracil (5-FU)." | 3.70 | Pseudomyxoma peritonei: Sudden cardiac death complicating post operative intraperitoneal treatment with 5-fluorouracil. ( El-Attar, AF; Howard, JM; Skeel, RT, 1999) |
| "Four patients with pseudomyxoma peritonei associated with mucinous tumors of the ovary were treated with cytoreductive surgery followed by intraperitoneal (IP) 5-fluorouracil (5-FU)." | 3.68 | Pseudomyxoma peritonei: treatment with intraperitoneal 5-fluorouracil. ( Given, FT; Kemp, GM; Nasr, MF, 1993) |
| "Intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil has been used to rescue patients from peritoneal carcinomatosis after perforated cystadenocarcinoma of the large bowel or appendix." | 3.68 | Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. ( Jaffe, G; Landy, D; Pascal, R; Sugarbaker, PH, 1990) |
| "The purpose of our study was to determine the maximum-tolerated dose, dose-limiting toxicity, safety profile, and pharmacokinetics of the polyamine synthesis inhibitor SAM486A given in combination with 5-fluorouracil/leucovorin (5-FU/LV) in cancer patients." | 2.71 | Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer. ( Bootle, D; Bridgewater, J; Choi, L; de Bruijn, P; Eskens, FA; Ledermann, JA; Mueller, C; Planting, AS; Sklenar, I; Sparreboom, A; van Zuylen, L; Verweij, J, 2004) |
| "Pseudomyxoma peritonei is a disease that results from a perforated mucinous neoplasm of the appendix so that mucinous ascites and mucin-producing tumor cells are widely disseminated in a characteristic pattern throughout the abdomen and pelvis." | 1.46 | Management of an inguinal hernia in patients with pseudomyxoma peritonei. ( Sugarbaker, PH, 2017) |
| "Pseudomyxoma peritonei is a very rare condition, and even rarer in patients with history of cancer." | 1.43 | Pseudomyxoma Peritonei in a Patient with History of Breast Cancer. ( Hong, JU; Jung, TS; Lee, HJ; Lee, JY; Min, IS; Park, SH; Seock, CH, 2016) |
| "The modern treatment of pseudomyxoma peritonei is cytoreductive surgery plus intraperitoneal chemotherapy resulting in a survival of up to 70 percent after 20 years." | 1.35 | Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study. ( Hansen, F; Iversen, LH; Jess, P; Laurberg, S; Nielsen, MB; Rasmussen, PC, 2008) |
| "Diffuse pyogenic gelatinous ascites and a large cystic mass with a grayish wall, and a hard solid lesion in part were found." | 1.31 | Disseminated peritoneal adenomucinosis associated with a panperitonitis-like onset: report of a case. ( Kuroki, Y; Otagiri, S; Tsukada, K, 2001) |
| "Pseudomyxoma peritonei is a rare disease caused by a perforated adenoma of the appendix." | 1.29 | Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. ( Sugarbaker, PH; Zoetmulder, FA, 1996) |
| "Pseudomyxoma peritonei is an unusual malignancy arising from the goblet cells of the large bowel or appendix." | 1.27 | Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment. ( Kern, K; Lack, E; Sugarbaker, PH, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.04) | 18.7374 |
| 1990's | 11 (22.45) | 18.2507 |
| 2000's | 21 (42.86) | 29.6817 |
| 2010's | 11 (22.45) | 24.3611 |
| 2020's | 5 (10.20) | 2.80 |
| Authors | Studies |
|---|---|
| Shang, Z | 1 |
| Ferris, ZE | 1 |
| Sweeney, D | 1 |
| Chase, AB | 1 |
| Yuan, C | 1 |
| Hui, Y | 1 |
| Hou, L | 1 |
| Older, EA | 1 |
| Xue, D | 1 |
| Tang, X | 1 |
| Zhang, W | 1 |
| Nagarkatti, P | 1 |
| Nagarkatti, M | 1 |
| Testerman, TL | 1 |
| Jensen, PR | 1 |
| Li, J | 1 |
| Lin, YL | 1 |
| Zhang, J | 1 |
| Yan, FC | 1 |
| Jiang, X | 1 |
| Ma, R | 1 |
| Yang, ZR | 1 |
| Xu, HB | 1 |
| Peng, Z | 1 |
| Chen, Q | 1 |
| Li, Y | 2 |
| Hiraide, S | 1 |
| Komine, K | 1 |
| Sato, Y | 1 |
| Ouchi, K | 1 |
| Imai, H | 1 |
| Saijo, K | 1 |
| Takahashi, M | 2 |
| Takahashi, S | 1 |
| Shirota, H | 1 |
| Ishioka, C | 1 |
| Luo, M | 1 |
| Badhe, PV | 1 |
| Ravi Kiran, D | 1 |
| Seshadri, H | 1 |
| Pietrantonio, F | 1 |
| Maggi, C | 1 |
| Fanetti, G | 1 |
| Iacovelli, R | 1 |
| Di Bartolomeo, M | 1 |
| Ricchini, F | 1 |
| Deraco, M | 1 |
| Perrone, F | 1 |
| Baratti, D | 1 |
| Kusamura, S | 1 |
| Tamborini, E | 1 |
| Castano, A | 1 |
| Consonni, PV | 1 |
| Bossi, I | 1 |
| Gavazzi, C | 1 |
| Milione, M | 1 |
| Pelosi, G | 1 |
| de Braud, F | 1 |
| Choe, JH | 1 |
| Overman, MJ | 1 |
| Fournier, KF | 1 |
| Royal, RE | 1 |
| Ohinata, A | 1 |
| Rafeeq, S | 1 |
| Beaty, K | 1 |
| Phillips, JK | 1 |
| Wolff, RA | 1 |
| Mansfield, PF | 1 |
| Eng, C | 1 |
| Bjersand, K | 1 |
| Mahteme, H | 2 |
| Sundström Poromaa, I | 1 |
| Andréasson, H | 1 |
| Graf, W | 2 |
| Larsson, R | 1 |
| Nygren, P | 1 |
| Jung, TS | 1 |
| Hong, JU | 1 |
| Park, SH | 1 |
| Lee, HJ | 1 |
| Min, IS | 1 |
| Lee, JY | 1 |
| Seock, CH | 1 |
| Cravioto-Villanueva, A | 1 |
| Cavazos, M | 1 |
| Luna-Perez, P | 1 |
| Martinez-Gomez, H | 1 |
| Ramirez, ML | 1 |
| Solorzano, J | 1 |
| Montiel, H | 1 |
| Esquivel, J | 1 |
| Sugarbaker, PH | 12 |
| Farquharson, AL | 1 |
| Pranesh, N | 1 |
| Witham, G | 1 |
| Swindell, R | 1 |
| Taylor, MB | 1 |
| Renehan, AG | 1 |
| Rout, S | 1 |
| Wilson, MS | 1 |
| O'Dwyer, ST | 1 |
| Saunders, MP | 1 |
| Elias, D | 2 |
| Honoré, C | 1 |
| Ciuchendéa, R | 1 |
| Billard, V | 1 |
| Raynard, B | 1 |
| Lo Dico, R | 1 |
| Dromain, C | 1 |
| Duvillard, P | 1 |
| Goéré, D | 1 |
| Chen, CF | 1 |
| Huang, CJ | 1 |
| Kang, WY | 1 |
| Hsieh, JS | 1 |
| Sun, WL | 1 |
| Hutarew, G | 1 |
| Gradl, J | 1 |
| Gratzl, M | 1 |
| Denz, H | 1 |
| Fiegl, M | 1 |
| Gilly, F | 1 |
| Quenet, F | 1 |
| Bereder, JM | 1 |
| Sidéris, L | 1 |
| Mansvelt, B | 1 |
| Lorimier, G | 1 |
| Glehen, O | 1 |
| Ryan, DP | 1 |
| Engelman, JA | 1 |
| Ferrone, CR | 1 |
| Sahani, DV | 1 |
| Lisovsky, M | 1 |
| Chua, TC | 2 |
| Al-Zahrani, A | 1 |
| Saxena, A | 1 |
| Liauw, W | 2 |
| Zhao, J | 1 |
| Morris, DL | 3 |
| Fajardo, AD | 1 |
| Tan, B | 1 |
| Reddy, R | 1 |
| Fleshman, J | 1 |
| van Zuylen, L | 1 |
| Bridgewater, J | 1 |
| Sparreboom, A | 1 |
| Eskens, FA | 1 |
| de Bruijn, P | 1 |
| Sklenar, I | 1 |
| Planting, AS | 1 |
| Choi, L | 1 |
| Bootle, D | 1 |
| Mueller, C | 1 |
| Ledermann, JA | 1 |
| Verweij, J | 1 |
| Mohamed, F | 1 |
| Gething, S | 1 |
| Haiba, M | 1 |
| Brun, EA | 2 |
| Levitz, JS | 1 |
| Lichtman, SM | 1 |
| Iversen, LH | 2 |
| Rasmussen, PC | 2 |
| Wara, P | 1 |
| Buhl, L | 1 |
| Ambrose, NS | 1 |
| Laurberg, S | 2 |
| Güner, Z | 1 |
| Schmidt, U | 1 |
| Dahlke, MH | 1 |
| Schlitt, HJ | 1 |
| Klempnauer, J | 1 |
| Piso, P | 1 |
| Yan, TD | 1 |
| Links, M | 1 |
| Xu, ZY | 1 |
| Kam, PC | 1 |
| Glenn, D | 1 |
| Dang, A | 1 |
| Mansfield, P | 1 |
| Ilsin, B | 1 |
| Hightower, C | 1 |
| Aravindan, N | 1 |
| Rice, D | 1 |
| Riedel, B | 1 |
| Ishibashi, K | 1 |
| Sobajima, J | 1 |
| Okada, N | 1 |
| Ishizuka, N | 1 |
| Yokoyama, M | 1 |
| Mitsuhashi, T | 1 |
| Miyazaki, T | 1 |
| Nakada, H | 1 |
| Gonda, T | 1 |
| Ishida, H | 1 |
| Jess, P | 1 |
| Nielsen, MB | 1 |
| Hansen, F | 1 |
| Jähne, J | 1 |
| Lang, H | 1 |
| Meyer, HJ | 1 |
| Pichlmayr, R | 1 |
| Sullivan, MH | 1 |
| Nasr, MF | 1 |
| Kemp, GM | 1 |
| Given, FT | 1 |
| Sasaki, A | 2 |
| Terashima, M | 2 |
| Okamoto, K | 2 |
| Ikeda, K | 2 |
| Takagane, A | 2 |
| Takiyama, I | 2 |
| Kuboi, M | 1 |
| Sasaki, N | 2 |
| Saito, K | 2 |
| Ronnett, BM | 1 |
| Archer, A | 1 |
| Averbach, AM | 1 |
| Bland, R | 1 |
| Chang, D | 1 |
| Dalton, RR | 1 |
| Ettinghausen, SE | 1 |
| Jacquet, P | 1 |
| Jelinek, J | 1 |
| Koslowe, P | 1 |
| Kurman, RJ | 1 |
| Shmookler, B | 1 |
| Stephens, AD | 1 |
| Steves, MA | 1 |
| Stuart, OA | 1 |
| White, S | 1 |
| Zahn, CM | 1 |
| Zoetmulder, FA | 3 |
| El-Attar, AF | 1 |
| Skeel, RT | 1 |
| Howard, JM | 1 |
| Hosch, WP | 1 |
| Rudi, J | 1 |
| Stremmel, W | 1 |
| Shimada, Y | 1 |
| Yamamoto, M | 1 |
| Nakajima, J | 1 |
| Witkamp, AJ | 1 |
| de Bree, E | 1 |
| Kaag, MM | 1 |
| van Slooten, GW | 1 |
| van Coevorden, F | 1 |
| Yan, H | 1 |
| Pestieau, SR | 1 |
| Shmookler, BM | 1 |
| Kuroki, Y | 1 |
| Otagiri, S | 1 |
| Tsukada, K | 1 |
| Butterworth, SA | 1 |
| Panton, ON | 1 |
| Klaassen, DJ | 1 |
| Shah, AM | 1 |
| McGregor, GI | 1 |
| Matsuoka, Y | 1 |
| Ohtomo, K | 1 |
| Itai, Y | 1 |
| Nishikawa, J | 1 |
| Yoshikawa, K | 1 |
| Sasaki, Y | 1 |
| Landy, D | 1 |
| Jaffe, G | 1 |
| Pascal, R | 1 |
| Kern, K | 1 |
| Lack, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase I Trial of Intraperitoneal Oxaliplatin in Combination With Intravenous FOLFIRI (5-fluorouracil, Leucovorin and Irinotecan) for Peritoneal Carcinomatosis From Colorectal and Appendiceal Cancer[NCT02833753] | Phase 1 | 14 participants (Actual) | Interventional | 2016-07-31 | Completed | ||
| An Interpretative Phenomenological Analysis of 'Recovery' Following Complete Cytoreductive Surgery.[NCT04125225] | 0 participants (Actual) | Observational | 2019-11-01 | Withdrawn (stopped due to No participants enrolled.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for fluorouracil and Pseudomyxoma Peritonei
| Article | Year |
|---|---|
[Pseudomyxoma peritonei--a syndrome with varying prognosis].
Topics: Adult; Antimetabolites, Antineoplastic; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Perit | 2003 |
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
Topics: Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Combined Modality Therapy; Fl | 2006 |
Pseudomyxoma peritonei syndrome.
Topics: Antimetabolites, Antineoplastic; Fluorouracil; Humans; Peritoneal Neoplasms; Prognosis; Pseudomyxoma | 1996 |
3 trials available for fluorouracil and Pseudomyxoma Peritonei
| Article | Year |
|---|---|
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antige | 2008 |
Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer.
Topics: Adult; Aged; Amidines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Coloni | 2004 |
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplas | 2006 |
43 other studies available for fluorouracil and Pseudomyxoma Peritonei
| Article | Year |
|---|---|
Grincamycins P-T: Rearranged Angucyclines from the Marine Sediment-Derived
Topics: Anthraquinones; Antineoplastic Agents; Biological Products; California; Cell Line, Tumor; Drug Scree | 2021 |
Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil.
Topics: Animals; Carcinoma, Signet Ring Cell; Female; Fluorouracil; Humans; Injections, Intraperitoneal; Mal | 2020 |
Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Fem | 2020 |
Is it a case series? Comment on "Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei".
Topics: Fluorouracil; Humans; Peritoneal Neoplasms; Pseudomyxoma Peritonei | 2021 |
Pseudomyxoma retroperitonei masquerading as a psoas abscess.
Topics: Appendix; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Pseudomyxoma Peritonei; Psoas Absce | 2021 |
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; DNA Methylation; | 2014 |
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N | 2015 |
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Prolifera | 2015 |
Pseudomyxoma Peritonei in a Patient with History of Breast Cancer.
Topics: Abdomen; Aged; Antimetabolites, Antineoplastic; Ascites; Breast Neoplasms; Colonoscopy; Female; Fluo | 2016 |
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; | 2016 |
Management of an inguinal hernia in patients with pseudomyxoma peritonei.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N | 2017 |
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Fem | 2008 |
Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Che | 2008 |
Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabine.
Topics: Adenoma, Villous; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized | 2009 |
Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; France; Humans; H | 2010 |
Case records of the Massachusetts General Hospital. Case 19-2010. A 35-year-old man with adenocarcinoma of the cecum.
Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Com | 2010 |
Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.
Topics: Adult; Antineoplastic Agents; Cell Differentiation; Cell Transformation, Neoplastic; Disease Progres | 2010 |
Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Blood | 2012 |
Delayed repeated intraperitoneal chemotherapy after cytoreductive surgery for colorectal and appendiceal carcinomatosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Colorectal Neopl | 2012 |
Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Agents; Female; Fluorouracil; Humans; Male; Middle Aged; M | 2004 |
Unusual abdominal tumors, case 1. Pseudomyxoma peritonei: response to capecitabine.
Topics: Abdominal Neoplasms; Adenocarcinoma, Mucinous; Appendiceal Neoplasms; Capecitabine; Deoxycytidine; F | 2004 |
[Extensive peritonectomy. A new treatment approach to pseudomyxoma peritonei].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemot | 2004 |
Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2005 |
Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.
Topics: Adult; Anesthesia, General; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemothera | 2007 |
[A case of pseudomyxoma peritonei successfully treated with multidisciplinary treatment including modified FOLFOX6 regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Colonoscopy; Fluorouracil; Hu | 2007 |
Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluo | 2008 |
[Possibilities and limits of surgical therapy of pseudomyxoma peritonei].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Ther | 1993 |
Treatment of pseudomyxoma peritonei in a geriatric patient population.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit | 1995 |
Pseudomyxoma peritonei: treatment with intraperitoneal 5-fluorouracil.
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; F | 1993 |
[Two cases of pseudomyxoma peritonei that responded to intraperitoneal administrations of a combined CDDP, 5-FU and MMC therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administrati | 1996 |
Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin.
Topics: Abdomen; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Chemotherapy, | 1996 |
Pseudomyxoma peritonei: Sudden cardiac death complicating post operative intraperitoneal treatment with 5-fluorouracil.
Topics: Adult; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Death, Sudden, Cardiac; Fluorouracil | 1999 |
Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Chemotherapy, Ad | 1999 |
[Intraperitoneal administration of a combined CDDP, 5-FU and MMC therapy for pseudomyxoma peritonei].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Cisplati | 1999 |
Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemothera | 2001 |
Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; | 2001 |
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Digestive Syste | 2001 |
Disseminated peritoneal adenomucinosis associated with a panperitonitis-like onset: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Combined Modality Therapy; Diagn | 2001 |
Cytoreduction including total gastrectomy for pseudomyxoma peritonei.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bile; Blood Loss, Surgical; Combined Modality Therapy; | 2002 |
Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Digestive System S | 2002 |
Pseudomyxoma peritonei with progressive calcifications: CT findings.
Topics: Adult; Aged; Calcinosis; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomyci | 1992 |
Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Colonic Neoplasm | 1990 |
Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment.
Topics: Adenocarcinoma, Mucinous; Adult; Colonic Neoplasms; Combined Modality Therapy; Drug Therapy, Combina | 1987 |